The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

(HealthDay News) — The US Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at ...

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.

Jim Richards doesn’t look like a mad scientist and his plant-based milk made from macadamia nuts tastes delicious. Yet his ...

WASHINGTON (AP) — Robert F. Kennedy Jr. has said vaccines are not safe. His support for abortion access has made ...

The Philippine Dermatological Society (PDS) has warned the public about the risks of intravenous (IV) glutathione following a ...

With two top Trump administration officials in Chicago, federal law enforcement began a “targeted” immigration blitz Sunday, ...

In this week’s installment of Curious Iowa, The Gazette answers a question about the work of county public health departments ...

Biologics License Applications for AVT05, their proposed biosimilar to the anti-inflammatory drugs Simponi and Simponi Aria. Review of the applications is expected to by completed in Q4 2025, ...

As research continues, those involved say this would be a game changer, especially for patients with very limited options.

The Democratic Party has so far been splintered in responding to President Donald Trump’s push against illegal immigration.